Thus far in February 2025, the stock surged 15% after the company registered a 10.5% YoY growth in exports in January 2025 on the back of stable demand for its products in the overseas markets.
According to CEO Srikrishna Ramakarthikeyan, the re-listing of the mid-tier IT company will not change its focus or business ...
Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...
Globe Telecom is still keen on a Philippine IPO for GCash but wants to public float smaller than the 20 percent required by the PSE and SEC.